These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19023658)

  • 1. Longitudinal effects of LAAM and methadone maintenance on heroin addict behavior.
    Anglin MD; Conner BT; Annon JJ; Longshore D
    J Behav Health Serv Res; 2009 Apr; 36(2):267-82. PubMed ID: 19023658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levo-alpha-acetylmethadol (LAAM) versus methadone maintenance: 1-year treatment retention, outcomes and status.
    Anglin MD; Conner BT; Annon J; Longshore D
    Addiction; 2007 Sep; 102(9):1432-42. PubMed ID: 17697277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.
    Longshore D; Annon J; Anglin MD; Rawson RA
    Addiction; 2005 Aug; 100(8):1131-9. PubMed ID: 16042643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of thrice weekly LAAM and daily methadone in employed heroin addicts.
    Freedman RR; Czertko G
    Drug Alcohol Depend; 1981 Nov; 8(3):215-22. PubMed ID: 7327086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.
    Borg L; Ho A; Wells A; Joseph H; Appel P; Moody D; Kreek MJ
    J Addict Dis; 2002; 21(3):13-22. PubMed ID: 12094997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia.
    Ritter AJ; Lintzeris N; Clark N; Kutin JJ; Bammer G; Panjari M
    Addiction; 2003 Nov; 98(11):1605-13. PubMed ID: 14616187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of methadyl acetate (LAAM) as compared with methadone in a treatment program for heroin addicts.
    Trueblood B; Judson BA; Goldstein A
    Drug Alcohol Depend; 1978 Mar; 3(2):125-32. PubMed ID: 631012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levo-alpha-acetylmethadol (LAAM): clinical, research, and policy issues of a new pharmacotherapy for opioid addiction.
    Prendergast ML; Grella C; Perry SM; Anglin MD
    J Psychoactive Drugs; 1995; 27(3):239-47. PubMed ID: 8594167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LAAM maintenance vs methadone maintenance for heroin dependence.
    Clark N; Lintzeris N; Gijsbers A; Whelan G; Dunlop A; Ritter A; Ling W
    Cochrane Database Syst Rev; 2002; (2):CD002210. PubMed ID: 12076441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between LAAM-methadone preference and treatment outcomes.
    White JM; Danz C; Kneebone J; La Vincente SF; Newcombe DA; Ali RL
    Drug Alcohol Depend; 2002 May; 66(3):295-301. PubMed ID: 12062464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levo-alpha-acetylmethadol (LAAM) induced QTc-prolongation - results from a controlled clinical trial.
    Wieneke H; Conrads H; Wolstein J; Breuckmann F; Gastpar M; Erbel R; Scherbaum N
    Eur J Med Res; 2009 Jan; 14(1):7-12. PubMed ID: 19258204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early clinical studies of levo-alpha acetylmethadol (LAAM): an opiate for use in the medical treatment of chronic heroin dependence.
    Blaine JD
    NIDA Res Monogr; 1978; (19):249-59. PubMed ID: 106289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. l-Alpha-acetylmethadol (LAAM): prognostic considerations.
    Resnick RB; Orlin L; Geyer G; Schuyten-Resnick E; Kestenbaum RS; Freedman AM
    Am J Psychiatry; 1976 Jul; 133(7):814-9. PubMed ID: 937573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal].
    Patricio LD; Miguel N
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():28-30. PubMed ID: 7880010
    [No Abstract]   [Full Text] [Related]  

  • 15. Opioid agonist maintenance for probationers: patient-level predictors of treatment retention, drug use, and crime.
    Gryczynski J; Kinlock TW; Kelly SM; O'Grady KE; Gordon MS; Schwartz RP
    Subst Abus; 2012; 33(1):30-9. PubMed ID: 22263711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (--)-alpha-Acetylmethadol effects on alcohol and diazepam use, sexual function and cardiac function.
    Hargreaves WA; Tyler J; Weinberg JA; Sorensen JL; Benowitz N
    Drug Alcohol Depend; 1983 Dec; 12(4):323-32. PubMed ID: 6671416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
    Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
    Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levo-alpha-acetylmethadol (LAAM) in the treatment of heroin addicts. I. Dosage schedule for induction and stabilization.
    Judson BA; Goldstein A
    Drug Alcohol Depend; 1979 Nov; 4(6):461-6. PubMed ID: 533680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
    Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
    J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of the evaluation of LAAM as a maintenance drug for heroin addicts.
    Ling W; Charuvastra VC; Klett CJ
    Am J Drug Alcohol Abuse; 1975; 2(3-4):307-15. PubMed ID: 775968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.